Showing Results for: “diabetes exercise”

People with type 2 diabetes should be considered in remission after sustaining normal blood glucose (sugar) levels for three months or more, according to a new consensus statement from the American Diabetes Association ® (ADA), the Endocrine Society, the European Association for the Study of Diabetes and Diabetes UK jointly published in Diabetes Care , the J ournal of Clinical Endocrinology & Metabolism , Diabetologia , and Diabetic Medicine , respectively. About 10% of the U.S. population has diabetes , and these numbers continue to rise. People with type 2 diabetes can achieve “remission” by

Study shows diabetes patients not taking medication experienced longer hospitalization and recovery with greatest toll among Latinx populations A new study reveals unmanaged diabetes is a key factor in COVID-19 severity and complications, particularly among Hispanic and Latinx populations. Findings of the retrospective study were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Forty percent of Americans who have died of COVID-19 have had diabetes, and 1 in 10 people with diabetes hospitalized for COVID-19 die within one week – making diabetes a

Analysis of large international DAPA-HF trial participants notes diabetes prevention benefit in patients with heart failure who took 10 mg of medication The SGLT2 inhibitor dapagliflozin, when used in patients with heart failure, provided a benefit in preventing type 2 diabetes (T2D), according to the study, “Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF,” presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions. The original DAPA-HF trial was a phase 3 placebo-controlled international study of

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment.

As a longtime professional volunteer and national board member of the American Diabetes Association® (ADA), Mary de Groot, Ph.D. has spent over two decades treating and helping people living with diabetes.

Brent Adame lives in Midwest City, Oklahoma, and is committed to thriving despite living with type 2 diabetes. This is his story: A couple of weeks before COVID-19 shut the economy down, I noticed my eyesight was getting blurry and my appetite was insatiable! I continued with my lifestyle, afraid to go to the doctor. I tested my glucose levels at a friend's about a month ago and was 359 and at one point 401. I got nervous and blew it off for a week. Then I got diabetic ketoacidosis (DKA) and nearly died. Learn about DKA I checked myself out of the hospital about 34 hours later. I assumed I'd

(NAPS)—Gestational diabetes is something to be concerned about after and not just during pregnancy. Gestational diabetes is diabetes that is found for the first time when a woman is pregnant. If you had gestational diabetes when you were pregnant, you and your child from that pregnancy have a lifelong risk for developing diabetes, a serious disease that can lead to health problems such as heart disease, blindness, kidney disease and amputations. The good news is there are steps you can take to prevent or delay type 2 diabetes and lower that risk for you and your child. Get Tested for Diabetes

First-of-its-Kind Program Addresses Growing Need for Improved Diabetes Care Today, the American Diabetes Association® (ADA) announced a new partnership with The Leapfrog Group, an independent national watchdog focused on health care safety, to launch the first-ever national designation program that will recognize hospitals demonstrating a strong commitment to the safety and well-being of inpatients who are living with diabetes. “Studies show that patients with diabetes often face heightened risks of serious health complications when visiting hospitals. That is especially true for patients of

The American Diabetes Association announces a new partnership to advance consumer resources for successful foot care The American Diabetes Association ® (ADA), the nation’s leading volunteer health organization, announced a new partnership with Dr. Comfort, to provide foot care resources on an ADA platform in a journey-driven experience for those living with diabetes and their caregivers. Dr. Comfort is a national sponsor of Living with Diabetes: Foot Care & Amputation . The Foot Care & Amputation section of the platform leads each user to learn to care for their feet, understand foot

Today, the American Diabetes Association ® (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) published a joint consensus report addressing diabetes management in chronic kidney disease (CKD). A joint writing group of ADA and KDIGO representatives reviewed and developed a series of consensus statements that provide clear direction for implementation of care to improve clinical outcomes for people with diabetes and CKD. The organizations aligned in areas of CKD screening and diagnosis, glycemia monitoring, lifestyle therapies, treatment goals, and pharmacologic management. “It is